Search

Search

このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

ホーム
...
研究分野生物医学と臨床科学腫瘍学とがん発生予測・予測マーカー
遠隔転移性原発性鼻性メラノーマの分子特性と治療戦略の探求

遠隔転移性原発性鼻性メラノーマの分子特性と治療戦略の探求

Dong Ren ¹, Chenchen Niu ¹, Nyein Nyein Htun ¹, Xin Zhang ², Jiadi He ², Ronggang Li ³, Qiongru Liu ³, Vincent Lee ¹, Robert A Edwards ¹, Grace G Zhou ⁴, Brandon M Lehrich ⁵, Derek H Liu ⁶, Angie Nguyen ⁷, Jeff Chan ¹, Nicholas R Pannunzio ⁴, Edward C Kuan ⁶, Beverly Y Wang ¹

Dong Ren ¹, Chenchen Niu ¹, Nyein Nyein Htun ¹

¹Department of Pathology and Laboratory Medicine, University of California, Irvine, CA, USA.
²Clinical Experimental Center, Jiangmen Engineering Technology Research Center of Clinical Biobank and Translational Research, Jiangmen Key Laboratory of Precision and Clinical Translation Medicine, Jiangmen Central Hospital, Jiangmen, China.
³Department of Pathology, Jiangmen Central Hospital, Jiangmen, China.
⁴Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Irvine, CA, USA.
⁵University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
⁶Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, CA, USA.
⁷Department of Biological Chemistry, University of California, Irvine, CA, USA.

⁰Department of Pathology and Laboratory Medicine, University of California, Irvine, CA, USA.

Laboratory Investigation; a Journal of Technical Methods and Pathology +

|

2025年9月6日

関連する実験動画

These videos have been matched automatically. Contact us if they are not relevant.

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs

Published on: May 24, 2016

See all related videos

PubMedで要約を見る

まとめ

この要約は機械生成です。

遠隔転移 (SNMM-M) による鼻膜メラノーマ (SNMM) は,異なる分子特性を示しています. SLX4変異は生存率の低下と関連しており,SNMM- MではCDK4増強/増幅が一般的であり,潜在的な治療目標を示唆しています.

科学分野

腫瘍学
ゲノミクス
分子病理学

背景

シノナス粘膜メラノーマ (SNMM) は,特に遠隔転移 (SNMM-M) で,生存率が低い希少で攻撃的な癌です.
SNMM-Mの分子基盤を理解することは,新しい治療戦略を特定するために不可欠です.

研究の目的

SNMM-Mの組織病理学的および分子的な風景を特徴づける.
SNMM-Mの潜在的な治療目標と予後バイオマーカーを特定する.

主な方法

ターゲットのDNAとRNAの次世代配列解析
免疫ヒストケミストリー (IHC) と光 in situ ハイブリデーション (FISH).
転移性 (SNMM-M) と非転移性 (SNMM-nM) 症例の比較ゲノム分析

主要な成果

SNMM- Mの症例では,上皮細胞形態,腫瘍死滅,腫瘍浸透性リンパ球 (TILs) の稀少さ,急性TILsの欠如が転移と関連し,生存率が低下した.
SLX4変異は,SNMM-Mでのみ発見され,全生存率の低下と有意に相関していました.
SNMM- nMでは,濃縮レセプターチロシンキナーゼおよび同類復合修復 (HRR) 遺伝子変異と対照的に,CDK4の増加/増幅が頻繁であった.

結論

SLX4変異は,SNMMの予後バイオマーカーとして機能する.
CDK4阻害剤は,SNMM-Mの治療選択肢として有望である.
これらの発見を確認するには,より大きなコホートでのさらなる検証が必要である.

キーワード:

CDK4 阻害剤 SLX4変異シノナス粘膜メラノーマ遠隔転移標的型DNAとRNAのシーケンシング治療調査

関連する実験動画

自動的に一致したビデオです Contact us もしそれらが関連していない場合

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs

Published on: May 24, 2016

See all related videos

関連する概念動画

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Share

X
Facebook
LinkedIn
YouTube

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

AUTHORS

Publishing Process
Editorial Board
Scope & Policies
Peer Review
FAQ
Submit

LIBRARIANS

Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

RESEARCH

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

EDUCATION

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Terms & Conditions of Use
Privacy Policy
Policies